Real-World Experience With Avacopan in Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis

Introduction: Postmarketing data on outcomes of avacopan use in antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV) are lacking. Methods: We performed a multicenter retrospective analysis of 92 patients with newly diagnosed or relapsing AAV who received therapy with avacopan....

Cijeli opis

Bibliografski detalji

Glavni autori:	Reza Zonozi, Faten Aqeel, Dustin Le, Frank B. Cortazar, Jugal Thaker, Maria Jose Zabala Ramirez, Sebastian Eduardo Sattui Cortes, Rose Mary Attieh, Madeline Chung, David H. Bulbin, Aisha Shaikh, Karina Guaman, Julia Ford, Colin Diffie, Ora Gewurz-Singer, Gabriel Sauvage, Anushya Jeyabalan, Abdallah Geara, Isabelle Ayoub, Andrew Bomback, Lara L. Khoury, Jason C. George, Kenar D. Jhaveri, Vimal Kumar Derebail, John L. Niles, Duvuru Geetha
Format:	Artigo
Jezik:	Inglês
Izdano:	Elsevier 2024-06-01
Serija:	Kidney International Reports
Teme:	avacopan ANCA-associated vasculitis complement remission kidney recovery
Online pristup:	http://www.sciencedirect.com/science/article/pii/S246802492401605X
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!